Eirion Therapeutics
Klaus Theobald is currently the Chief Research & Development Officer at Eirion Therapeutics Inc. Prior to this, Klaus held the same position at Anterios, Inc. Klaus has extensive experience in the pharmaceutical and biotech industry, with notable roles such as Sr. VP & Chief Medical Officer at CollaGenex Pharmaceuticals and President and CEO at Allergenics, Inc. Klaus has a background in immunology and clinical research, with a Ph.D. in Allergy and Immunology Residency Program. Their expertise spans across various therapeutic areas, including immunology, hemostasiology, critical care, and cancer.
This person is not in any offices